SCA
IONS icon

SAC Capital Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

SAC Capital Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-74,106
Closed -$3.2M – 502
2014
Q1 		$3.2M Buy
74,106
+65,575
+769% +$3.18M 0.02% 653
2013
Q4 		$340K Sell
8,531
-58,868
-87% -$2.1M ﹤0.01% 1350
2013
Q3 		$2.53M Buy
67,399
+40,292
+149% +$1.2M 0.01% 683
2013
Q2 		$728K Buy
+27,107
New +$576K ﹤0.01% 989

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAC Capital Advisors's IONS Position: Q2 2014 in Review

SAC Capital Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2014, closing a stake of 74,106 shares — an estimated $3.2M sold.

SAC Capital Advisors first reported a position in IONS in Q2 2013 and held it in 4 quarters. The position peaked at $3.2M in Q1 2014. 238 funds tracked by Wall St. Rank hold IONS as of Q2 2014.

  • SAC Capital Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 74,106 Ionis Pharmaceuticals shares in Q2 2014, an estimated $3.2M.
  • SAC Capital Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Ionis Pharmaceuticals position peaked at $3.2M in Q1 2014.
  • 238 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.